UTI Mutual Fund

From WebNotes, a public knowledge base. Last updated . Reading time ~13 min.

UTI Mutual Fund is an Indian asset management company, formally incorporated as UTI Asset Management Company Limited (UTI AMC), and the institutional successor to the market-linked mutual fund business of the Unit Trust of India following the statutory bifurcation in 2003. The AMC manages assets across equity, debt, hybrid, passive, and solution-oriented categories. As of March 2024, UTI AMC managed assets in excess of Rs 2.8 lakh crore and is listed on the National Stock Exchange and Bombay Stock Exchange following its IPO in September–October 2020.

UTI Mutual Fund occupies a distinctive position in India’s asset management landscape: it is the only AMC co-sponsored by four government-owned financial institutions, the State Bank of India (SBI), Punjab National Bank (PNB), Bank of Baroda (BoB), and Life Insurance Corporation of India (LIC). Each holds approximately 18.5% of UTI AMC’s equity, while a strategic foreign investor (T. Rowe Price International Ltd of the United States) holds approximately 23%, with the remaining shares held by public investors post-IPO.

The fund house manages one of the two designated EPFO equity ETF mandates (the Sensex ETF tranche), alongside SBI Mutual Fund which manages the Nifty 50 ETF tranche. UTI AMC’s passive book, anchored by institutional mandates, constitutes a significant share of its total AUM.

History and corporate structure

Unit Trust of India origins (1963–2002)

The history of UTI Mutual Fund begins with the Unit Trust of India, established by an Act of Parliament in 1963. UTI was the first and sole mutual fund entity in India for over two decades, offering units to retail investors through its US-64 scheme, which operated more as a quasi-guaranteed savings product than a mark-to-market investment vehicle.

For the detailed history of the Unit Trust of India as a statutory body, including the US-64 crisis, see Unit Trust of India.

Bifurcation under the UTI Repeal Act (2002–2003)

The Unit Trust of India (Transfer of Undertaking and Repeal) Act, 2002, bifurcated UTI’s operations into two entities:

  1. Specified Undertaking of the Unit Trust of India (SUUTI): Took over the assured-return schemes (including US-64 and Unit Scheme 1964), relieved by a government backstop. SUUTI is not a SEBI-registered mutual fund; it operates under government administration and has been progressively winding down its obligations.

  2. UTI Mutual Fund: The new SEBI-registered entity that took over the market-linked NAV-based schemes from the old UTI. UTI AMC was incorporated as the AMC, and UTI Trustee Company Private Limited was established as the trustee.

The four government sponsors (SBI, PNB, BoB, LIC) were designated co-sponsors of the new UTI AMC, each contributing to the minimum sponsor net worth requirements and governance framework.

Strategic partnership with T. Rowe Price (2010)

T. Rowe Price International Ltd, the UK-based subsidiary of the American investment management firm T. Rowe Price, acquired a 26% stake in UTI AMC in 2010 for approximately Rs 694 crore, valuing UTI AMC at Rs 2,668 crore at the time. The investment was intended to bring global institutional asset management expertise, particularly in equity research and client servicing for overseas investors. T. Rowe Price’s holding was partially diluted by the IPO but remained a significant minority.

IPO and public listing (2020)

UTI AMC conducted its initial public offering in September–October 2020, listing on NSE and BSE in November 2020. The IPO was an offer for sale by the four government sponsors, who each reduced their stakes. Post-IPO, each government sponsor holds approximately 18.5%, T. Rowe Price holds approximately 23%, and public shareholders hold the remainder.

The IPO was one of the largest in the Indian AMC sector and provided the fund house with market visibility, enhanced governance obligations, and a public market valuation. UTI AMC’s market capitalisation post-listing has been compared by analysts with that of HDFC Mutual Fund (listed 2018) and Nippon India Asset Management (listed 2017).

EPFO ETF mandate

UTI AMC is one of two designated AMCs (alongside SBI Mutual Fund) that manage the Employees’ Provident Fund Organisation’s equity ETF mandate. UTI manages the Sensex ETF tranche, while SBI manages the Nifty 50 ETF tranche. Cumulative EPFO equity investments across both AMCs exceeded Rs 2.5 lakh crore by 2024. This mandate provides a large, predictable, and low-cost institutional AUM base.

UTI Mutual Fund is co-sponsored by State Bank of India, Punjab National Bank, Bank of Baroda, and Life Insurance Corporation of India, each holding approximately equal shares. T. Rowe Price International Ltd is the strategic foreign investor. The trustee entity is UTI Trustee Company Private Limited.

Key service providers:

  • Registrar and Transfer Agent: KFin Technologies Limited (formerly Karvy Computershare)
  • Custodian: HDFC Bank Limited
  • Depository: NSDL and CDSL

Scheme portfolio

Passive schemes

UTI AMC’s largest passive offerings:

  • UTI Nifty 50 ETF: The Sensex (BSE-benchmarked) portion of the EPFO mandate; however, the scheme tracking the Nifty 50 is also managed by UTI alongside SBI MF.
  • UTI Sensex ETF and UTI Sensex Index Fund: The primary vehicles for the EPFO Sensex mandate; among the largest ETFs and index funds by AUM in India.
  • UTI Nifty Next 50 ETF and UTI Nifty Next 50 Index Fund: Broader market passive exposure.
  • UTI Nifty 200 Momentum 30 Index Fund: Factor-based passive product.
  • UTI S&P BSE Low Volatility ETF: Low volatility factor ETF.

Equity schemes

  • UTI Mastershare Unit Scheme: One of the oldest equity mutual fund schemes in India, launched in 1986 under the old UTI and transferred to the new UTI AMC in 2003. Long track record as a large cap-oriented fund.
  • UTI Flexi Cap Fund: Core flexi cap equity offering.
  • UTI Midcap Fund: Mid cap mandate with a reasonable track record.
  • UTI Small Cap Fund: Small cap exposure.
  • UTI Long Term Equity Fund (ELSS): Tax-saving equity fund.
  • UTI Transportation and Logistics Fund: Sector/thematic fund with a long history.
  • UTI Healthcare Fund: Sector fund.

Debt schemes

Comprehensive debt category coverage including liquid, overnight, short duration, money market, medium duration, corporate bond, banking and PSU, and gilt. UTI AMC’s debt schemes have a significant institutional investor base, partly attributable to the trust that government-sponsored institutions place in the UTI brand.

Hybrid and solution-oriented schemes

  • UTI Hybrid Equity Fund: Balanced hybrid with a long track record.
  • UTI Unit Linked Insurance Plan (ULIP): One of the earliest hybrid insurance-linked products offered under the old UTI framework; transferred to the new entity.
  • UTI Retirement Benefit Pension Fund: Among the oldest retirement-oriented mutual fund products in India.
  • UTI Children’s Career Fund: Long-standing children’s savings scheme.

Investment philosophy

UTI AMC’s active equity investment approach is research-driven with a blend of fundamental analysis and sector-level assessment. The fund house’s equity team has historically managed its flagship schemes with a growth orientation, tilted toward consistent earnings compounders. The passive segment operates with a tight tracking-error mandate given institutional client sensitivities.

The debt investment process emphasises credit quality and interest rate management, with a preference for government securities and high-rated corporate bonds. The government-sponsor identity and institutional investor base create implicit demands for conservative credit management.

Distribution and operations

UTI AMC’s distribution network benefits from the institutional relationships of its four government sponsors. SBI branches, PNB branches, Bank of Baroda branches, and LIC agents all serve as access points for UTI fund sales, providing deep pan-India reach including tier-3 and tier-4 cities.

The AMC’s RTA, KFin Technologies, provides investor servicing. Digital platforms including UTI’s own portal (utimf.com) and third-party platforms including Zerodha Coin enable direct plan investment.

Regulatory standing

UTI Asset Management Company Limited holds a valid SEBI registration. As a listed entity, it complies with SEBI LODR in addition to the SEBI (Mutual Funds) Regulations, 1996. The fund house has not faced material SEBI enforcement actions following the 2003 restructuring. The historical US-64 crisis is attributed to the old statutory UTI entity and not to UTI AMC, which was constituted fresh under SEBI regulation.

Notable events

  • 1963: Unit Trust of India established under Parliament Act; predecessor entity.
  • 2002: UTI (Transfer of Undertaking and Repeal) Act passed; UTI bifurcated.
  • 2003: UTI Mutual Fund and UTI AMC commence operations as SEBI-registered entities.
  • 2010: T. Rowe Price acquires 26% strategic stake.
  • 2015: Designated as one of two EPFO ETF managing AMCs (Sensex tranche).
  • September–October 2020: UTI AMC IPO; listed on NSE and BSE.
  • 2024: AUM exceeds Rs 2.8 lakh crore; EPFO mandate drives passive segment growth.

See also

References

  1. UTI Asset Management Company Limited, SEBI Registration. sebi.gov.in.
  2. UTI AMC Annual Report 2022-23. Available at utimf.com.
  3. UTI AMC IPO Prospectus, September 2020. UTI Asset Management Company Limited.
  4. AMFI Data, AMC-wise AUM, March 2024. Association of Mutual Funds in India.
  5. Unit Trust of India (Transfer of Undertaking and Repeal) Act, 2002. Government of India.
  6. “T. Rowe Price acquires 26% stake in UTI AMC for Rs 694 crore.” Business Standard, 2010.
  7. UTI AMC Q4 FY2024 Earnings Presentation.

Reviewed and published by

WebNotes Editorial Team

The WebNotes Editorial Team covers Indian capital markets, payments infrastructure and retail investor procedures. Every article is fact-checked against primary sources, principally SEBI circulars and master directions, NPCI specifications and the official support documentation published by the intermediary in question. Drafts go through a second-pair-of-eyes review and a separate compliance read before publication, and revisions are tracked against the SEBI and NPCI rule changes referenced in the methodology section.

Last reviewed
Conflicts of interest
WebNotes is independent. No relationship with any broker, registrar or bank named in this article.